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I n earlier reports from this insti-tution1 ,2 changes in hemostasis 
were described in five patients 
treated with orthotopic homotrans-
plantation of the liver. There was 
an intraoperative bleeding diathesis 
at the same time as fibrinolysis and 
hypofibrinogenemia developed. In 
four of the cases, the hemorrhage 
was eventually controlled after the 
administration of epsilon aminocap-
roic acid (EACA) , fibrinogen, and 
fresh blood. Subsequently, three of 
the four survivors formed thrombi 
at or near femoral venotomy sites 
which had been used fOl" the inser-
tion of external bypass catheters; in 
all three, the eventual result was 
multiple pulmonary embolization. 
Appreciation of the seriousness of 
these problems prompted a number 
of investigations to be performed in 
dogs and pigs2-5 to more fully char-
acterize the clotting abnormalities 
of liver transplantation and to learn 
If a succeeding period of hyperco-
agulability was an inherent part of 
the picture. It has been established 
from these studies that hepatic homo-
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transplantation can cause fibrinoly-
sis, thrombocytopenia, and depres-
sion of various clotting factors; that 
the extent of these changes are prog-
nostic inasmuch as they are propor-
tional to the magnitude of liver 
injury; and that the depression of 
clotting is not necessarily succeeded 
by hypercoagulability if thrombo-
genic agents are not administered. 
The present report, based on expe-
rience with ten more recent cases of 
clinical orthotopic transplantation, 
will show that the same conclusions 
apply in man. 
Methods 
The diseased recipient livers were 
removed and replaced with orthotopic 
homografts; splenectomy was concomi-
tantly carried out in all but two cases. 
External bypasses, to decompress the 
occluded splanchnic and inferior vena 
caval beds during the anhepatic phase, 
were not used. The ten patients were 
13 months to 43 years old. In the first 
two cases, organs were used that had 
sustained a severe ischemic injury as 
judged by high postoperative rises in 
the recipient serum transaminases, 
poo'r hepatic function from the outset 
including rapidly progressive jaundice, 
and death of the patients seven days 
and ten days later from combined he-
patic and renal failure. 
The next eight patients benefited 
from more discriminating donor selec-
tion and from the application of an 
effective technique for interim preser-
vation of the homografts.6 The liver 
lllJury was mild to moderate by the 
above criteria, and all patients had 
satisfactory early homograft function. 
Five patients with jaundice cleared 
their hyperbilirubinemia. In the three 
others, normal preoperative bilirubin 
levels remained unchanged, at least 
until the onset of rejection. All these 
eight recipients survived for at least 
orie month, and four are still alive 
after one to ten months with liver 
function that ranges from good to ex-
cellent. The details of these cases 
including the regimen of immuno-
suppreSsion have been reported 
elsewhere.7,B 
In seven of the ten patients coagula-
tion was studied several times during 
operation and, in all, the blood was 
examined at regular intervals thereaf-
ter. The battery of examinations and 
the techniques of analyses were the 
same as in a recent study of the same 
problem in dogs<!; the details of metI1-
odology will not be repeated here. The 
tests could be divided as follows on the 
basis of what tI1ey measure: 
A. Clotting Factors Known or 
Thought to be Produced by the Liver. 
-These included factors I (fibrino-
gen) , II (prothrombin), V (accelerator 
globulin), VII (proconvertin), IX 
(Christmas), and X (Stuart). Except 
for fibrinogen which was quantitated 
in mg/1oo cc, the results were ex-
pressed in percent of normal. In a few 
instances, the less specific Quick pro-
thrombin time was obtained. 
B. Extrahepatic Elements of Clot-
ting.-Factor VIII (antihemaphilic 
globulin) and platelets were measured. 
C. Indicators of Fibrinolysis.-The 
presence of plasmin (fibrinolysin) was 
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assayed directly with the heated fibrin 
plate method. Indirect evidence of 
fibrinolysis was sought with several 
methods. The latter involved tests to 
detect or to measure or both plasmino-
gen (which is low with fibrinolysis), 
plasminogen activators (determined 
with the unheated fibrin plate method 
or with euglobulin lysis times), and 
the products of partial fibrinogen de-
gradation (fibrinogen split products, 
FSP). 
D. Antithrombin Activity.-This 
was assayed by determining the 
thrombin time; in some samples with 
prolonged thrombin time the level of 
plasma heparin was measured. 
Results 
Severe Liver Injury.-These two 
patients were first studied in the 
postoperative period, at which time 
profoUnd coagulation abnormalities 
were present. In a 13-month-old 
child, whose original diagnosis was 
biliary atresia, the liver-produced 
factors II, V, IX, and X were all 
less than 15% of normal; fibrinogen 
was never higher than 125 mg/100 
cc (Fig 1). The Quick prothrombin 
time and the thrombin time were 
both extremely prolonged. In con-
trast, factor VIII was supernormal 
for the entire ten postoperative days 
(Fig 1). There was a progressive 
thrombocytopenia despite daily 
platelet infusions. Euglobulin lysis 
times (ELT) were prolonged. Hem-
orrhage was not troublesome until 
gastrointestinal bleeding became 
continuous during the last two days 
of life. 
A 28-year-old man with a hepato-
ma had similar but widely fluctuat-
ing changes. Bleeding was, however, 
a far more significant problem. Dur-
ing the operation and the seven 
postoperative days he received 33 
liters of blood and 3.5 liters of 
fibrinogen solution. 
Moderate or Mild Liver Injury. 
-Early: All the seven recipients in 
which intraoperative studies were 
obtained had similar changes which 
varied only in degree from case to 
case. None received thrombogenic 
agents. The courses of the two pa-
tients with the most and least pro-
found changes respectively are 
shown in Fig 2 and 3. The factors 
synthesized by the liver, which be-
gan to fall during the hepatectomy, 
decreased further during the anhe-
patic phase and reached a nadir 
shortly after the homograft was re-
vascularized. Factors V and IX 
were usually the most severely 
affected; factors II, VII, and X next; 
and fibrinogen the least. The altera-
tions in factor VIII, which is not 
produced in hepatic tissue, varied 
from profound depression (Fig 2) 
in some cases to a moderate de-
crease in others (Fig 3). The plate-
lets were transiently depressed in 
five of the seven patients. 
Following the anhepatic phase all 
patients had a marked activation of 
the fibrinolytic system as shown by 
Fig l.-Measures of coagulation and fibrinolysis in a 13· 
month·old child who never had satisfactory function of his 
orthotopic liver homograft. Note that factor VIII remained 
supernormal while all the liver·based coagulation factors were 
severely depressed. Euglobulin lysis time (ELT) was infinite. 
Fig 2.-lntraoperative and early postoperative coagulation 
changes in a 16·month·old child with life sustaining but im-
paired immediate homograft function. All coagulation factors 
studied were depressed below 50% of normal. These grad-
ually returned toward normal. FSP, Fibrinogen split products 
(see text). 
!IOO 
50 I - EibrinoQen l"o--v--.. -------------_~ ~ ------- .. _---.. 
)2OO.l ~~~ 200 . ----.\\ 
~ 100 ... '. _--,Platelet. ~-- '" 
, 
' .... ---........................ ---... -.. ~ ............ 
0 
:~ - _J;mmoo--omuoo--
60 
~"> 
.............. 
0 o 2 4 6 8 10 :---r--r~r--r-"D"":!::fl--:fOr- I ! 5 
DAYS 1------ -------il I--DAYS---I 
32 Arch Surg/Vol 98, Jan 1969 Coagulation and Liver Transplant/Groth et al 
the occurrence of lysis on heated 
plates, decreases in plasminogen 
levels, and shortening of the ELT. 
Concomitantly fibrinogen split prod-
ucts appeared in the serum. 
Prolongation of the thrombin 
time occurred after revasculariza-
tion of the homograft in all cases. 
In the patient with the most pro-
found changes in hemostasis meas-
urable amounts of plasma heparin 
(47 ,ug/ml) occurred at this time. 
Three other patients studied had no. 
detectable heparin in their plasma 
in spite of prolonged thrombin 
times. 
Two hours after revascularization 
of the homografts, a restitution of 
the clotting factors toward normal 
had generally begun. By this time, 
the studies of fibrinolysis also 
showed improvement (Fig 2 to 4). 
During the ensuing week the major-
ity of hemostatic parameters re-
turned to essentially normal levels. 
Exceptions were the platelets and 
plasminogen levels which usually 
remained subnormal for several 
weeks. There was little or no evi-
dence of delayed hypercoagula-
bility. 
Abnormal intraoperative bleeding 
was encountered only in the patient 
with the most profound alterations 
in hemostasis (Fig 2). The hemor-
rhagic state in this case was, how-
ever, transient. 
Late: The later postoperative 
course was studied in the eight best 
cases. The clotting values were 
closely correlated to the quality of 
homograft function as measured by 
standard liver function tests. The· 
patient with the longest survival 
(ten months) has had good liver 
function and essentially normal co-
agulation and fibrinolysis through-
out. Two patients who died of pro-
gressive liver failure 4Jf2 and 6 
months after transplantation had 
slowly declining levels of the clot-
ting factors synthesized by the liver 
as well as decreases in plasminogen 
(Fig 4). During this course, factor 
VIn remained unaffected. 
Comment 
Several mechanisms apparently 
account for the sudden decrease in 
clotting factors during orthotopic 
liver transplantation. The most im-
portant are probably consumption 
Fig 3.-Changes in a 14·month·old child with satis· 
factory immediate liver function. All coagulation factors 
studied were transiently but only minimally depressed. 
FSP, Fibrinogen split products. 
Fig 4.-Postoperative changes in a 20lh·month· 
old patient. Early homograft function was satis· 
factory but progressive liver failure due to chronic 
rejection subsequently developed. During the late 
course, factor VIII remained supernormal while the 
liver· based II and V and plasminogen ultimately 
declined. 
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of the coagulation factors due 
to intravascular coagulation,4 and 
counterregulatory fibrinolysis. Tem-
porary cessation of hepatic synthe-
sis is presumably a contributory fac-
tor. The precise mechanism of these 
changes has been discussed else-
where.1-4 In only one case could 
prolongation in thrombin time be 
related to the occurrence of plasma 
heparin as suggested by Stremple9 ; 
the trace quantities could have been 
due to the heparin solutions used to 
perfuse and flush the grafts.5.7 In 
the others, the antithrombic activity 
was attributable to the occurrence 
of fibrinogen split products.10 
In a recent laboratory study,4 it 
was shown that the severity of the 
hemostatic breakdown after ortho-
topic liver transplantation in dogs 
was related to the quality of the 
homografts. The conclusion was the 
same in the human cases herein 
reported. The two patients who re-
ceived livers badly damaged by is-
chemia developed profound and per-
sistent abnormalities in clotting 
while the recipients of well-preserved 
homografts had only minor or mod-
erate changes which were reversible. 
None of the latter patients required 
administration of clot promoting or 
antifibrinolytic agents. Moderate 
bleeding such as experienced in one 
of these patients should not neces-
sarily be regarded with alarm nor 
treated pharmacologically since 
spontaneous improvement can be 
expected. The avoidance of pharma-
cologic manipulation of hemostatis 
and omission of an external decom-
pressing bypass in the venous sys-
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tern undoubtedly helped prevent 
postoperative thromboembolism such 
as that seen in earlier cases.1 If 
treatment should become necessary 
for a hemorrhagic diathesis, it 
should be guided by frequent meas-
ures of clotting parameters. 
Although most of the clotting fac-
tors analyzed in this study are 
known to be synthesized in hepatic 
tissue, the origin of factor VIII (an-
tihemophilic globulin) remains ob-
scure. In several of the patients, 
who had also had splenectomy, fac-
tor VIII remained normal or super-
normal as the other factors declined 
concomitant with acute or chronic 
hepatic failure; in one such case, the 
recipient was essentially anhepatic 
(Fig 1). It thus appears that nei-
ther the spleen nor functional liver 
tissue are essential for the mainte-
nance of adequate levels of anti-
hemophilic globulin. 
Summary 
Orthotopic liver homotransplan-
tation in humans was accompanied 
by acute depression in multiple 
coagulation factors, thrombocyto-
penia, and pathologic fibrinolysis. 
Two patients with poor homograft 
function had severe and persistent 
changes; eight subsequent recipients 
with satisfactory immediate liver 
function developed only minor or 
moderate derangements which were 
reversible and did not require thera-
py with thrombogenic agents. Later 
in the course coagulation was nor-
mal except with the advent of 
chronic hepatic failure when depres-
sion occurred of the coagulation fac-
tors synthesized by the liver. 
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